Mayrovitz Harvey N, Ryan Shelly, Hartman James M
Department of Physiology, College of Medical Sciences, Nova Southeastern University, Fort Lauderdale, Florida.
Department of Lymphedema, Mercy Hospital St. Louis, St. Louis, Missouri.
Head Neck. 2018 Jan;40(1):137-143. doi: 10.1002/hed.24995. Epub 2017 Nov 13.
This functional usability study assessed ease of use, fit, comfort, and potential clinical benefits of advanced pneumatic compression treatment of cancer-related head and neck lymphedema.
Patient-reported comfort and other treatment aspects were evaluated and multiple face and neck measurements were obtained on 44 patients with head and neck lymphedema before and after 1 treatment session to assess usability and treatment-related lymphedema changes.
A majority of the patients (82%) reported the treatment was comfortable; most patients (61%) reported feeling better after treatment, and 93% reported that they would be likely to use this therapy at home. One treatment produced overall small but highly statistically significant reductions in composite metrics (mean ± SD) of the face (82.5 ± 4.3 cm vs 80.9 ± 4.1 cm; P < .001) and neck (120.4 ± 12.2 cm vs 119.2 ± 12.1 cm; P < .001) with no adverse events.
Results found the treatment to be safe, easy to use, and well tolerated while demonstrating edema reduction after a single initial treatment.
这项功能可用性研究评估了先进的气压治疗对头颈部癌症相关淋巴水肿的易用性、贴合度、舒适度及潜在临床益处。
评估患者报告的舒适度及其他治疗方面，并在44名头颈部淋巴水肿患者接受1次治疗前后进行多次面部和颈部测量，以评估可用性及与治疗相关的淋巴水肿变化。
大多数患者（82%）报告治疗过程舒适；大多数患者（61%）报告治疗后感觉好转，93%的患者表示可能会在家中使用这种疗法。一次治疗使面部（82.5±4.3厘米对80.9±4.1厘米；P<0.001）和颈部（120.4±12.2厘米对119.2±12.1厘米；P<0.001）的综合指标总体出现虽小但具有高度统计学意义的降低，且无不良事件。
结果表明该治疗安全、易用且耐受性良好，同时在单次初始治疗后即可减轻水肿。
